Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/22/1990 | CA1269205A1 Adsorption-resistant peptide composition |
05/21/1990 | CA2003382A1 Method for treating vascular diseases |
05/21/1990 | CA2003350A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
05/18/1990 | CA2002820A1 Pharmaceutical use for cystatins |
05/17/1990 | WO1990005191A1 Neurite growth regulatory factors |
05/17/1990 | WO1990005185A1 Modified human growth hormone |
05/17/1990 | WO1990005184A1 Expression and processing of authentic fgf's in yeast |
05/17/1990 | WO1990005183A1 Interleukin-4 receptors |
05/17/1990 | WO1990005180A1 Products and methods for controlling the suppression of the neoplastic phenotype |
05/17/1990 | WO1990005147A1 Natural killer stimulatory factor |
05/17/1990 | WO1990005146A1 Sequence specific gene repressor |
05/17/1990 | WO1990005144A1 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
05/17/1990 | WO1990005143A1 Anti-thrombins |
05/17/1990 | WO1990005142A1 Polypeptides |
05/17/1990 | WO1990005141A1 Amino acid and peptide inhibitors of human leukocytic elastase and collagenase |
05/17/1990 | WO1990005140A1 Process for producing a high-purity, non-infectious antihaemophilia factor by chromatography |
05/17/1990 | WO1990005138A1 Cytotoxic amyloid precursors and screening assays using them |
05/17/1990 | WO1990005103A1 A sheet feeding apparatus |
05/17/1990 | WO1990004979A2 Method of preventing or reducing eosinophilia |
05/17/1990 | WO1990004977A2 Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon |
05/17/1990 | WO1990004975A1 USE OF A LOW AFFINITY-HEPARIN FRACTION IN CONJUNCTION WITH t-PA FOR THROMBOLYTIC THERAPY |
05/17/1990 | WO1990004974A1 Method for the treatment of periodontal disease |
05/17/1990 | WO1990004973A1 Treatment of myelosuppression associated with acquired immune deficiency |
05/17/1990 | WO1990004917A1 Heterocyclic peptide renin inhibitors |
05/17/1990 | WO1990002802A3 Viral nucleotide sequences |
05/17/1990 | WO1990001927A3 Use of paf antagonists for treating autoimmune diseases |
05/17/1990 | CA2003211A1 Monoclonal antibodies |
05/17/1990 | CA2002854A1 Recombinant interleukin-2 hybrid proteins |
05/16/1990 | EP0368823A2 Biologically active lipoprotein and its use |
05/16/1990 | EP0368719A2 Novel analogs of peptidase substrates |
05/16/1990 | EP0368711A1 Method for the isolation of glycosylated interleukin-2, and glycosylated interleukin-2 |
05/16/1990 | EP0368684A1 Cloning immunoglobulin variable domain sequences. |
05/16/1990 | EP0368486A2 Novel inhibitors of platelet binding |
05/16/1990 | EP0368466A2 Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
05/16/1990 | EP0368449A2 Elastase inhibiting polymers and methods to produce them |
05/16/1990 | EP0368373A1 Multi-phase contraceptive preparation |
05/16/1990 | EP0368367A1 Purification, production and use of tumor necrosis factors |
05/16/1990 | EP0368232A1 Thrombolytic therapy |
05/16/1990 | EP0368187A2 Insulin derivatives, their use and a pharmaceutical composition containing same |
05/16/1990 | EP0368000A1 Use of sustained-release compositions containing GnRH, LHRH or derivatives thereof |
05/16/1990 | EP0367890A1 Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof |
05/16/1990 | EP0367840A1 Process for producing by chromatography a non-infectious antihemophilic factor with high purity |
05/16/1990 | EP0305297B1 Derivatives of aza-z-bicyclooctane-caboxylicacid-3, processes for their preparation and pharmaceutical compositions containing them |
05/16/1990 | EP0198745B1 Method for the microbiological synthesis of human serum albumin |
05/16/1990 | CN1042155A Neuropeptide y agonists and its non-full agonists |
05/16/1990 | CA2003110A1 Monoclonal antibody specifically recognizing n-glycolyl type gm , hydridoma producing the antibody and method for preparing the hybridoma |
05/15/1990 | US4925922 Potentiation of cytotoxic conjugates |
05/15/1990 | US4925920 Immunosuppressive polypeptides |
05/15/1990 | US4925919 Purified interleukin 2 |
05/15/1990 | US4925793 Human immune interferon |
05/15/1990 | US4925784 Expression and purification of an HTLV-III gag/env gene protein |
05/15/1990 | US4925673 Delivery systems for pharmacological agents encapsulated with proteinoids |
05/15/1990 | US4925574 Binding via hemoglobin polyanion binding site |
05/15/1990 | CA2002819A1 N-substituted amides |
05/15/1990 | CA1269042A1 Preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation |
05/14/1990 | CA2002869A1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof |
05/14/1990 | CA2002860A1 Antibodies specific for elam-1 and the use thereof |
05/14/1990 | CA2002004A1 Fish crf |
05/11/1990 | CA2002609A1 Binding proteins for insulin-like growth factors |
05/10/1990 | CA2441636A1 Natural killer stimulatory factor |
05/10/1990 | CA2000821A1 Inhibitors of platelet binding |
05/09/1990 | EP0367735A1 Use of gamma interferon in pharmaceutical preparations for the treatment of vascular stenosis |
05/09/1990 | EP0367713A1 Antidote for blood anticoagulants based on factor VIII |
05/09/1990 | EP0367644A1 Nucleotide sequence codings for a protein with urea reactivity |
05/09/1990 | EP0367641A2 Lymphokines, DNA sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines |
05/09/1990 | EP0367596A1 Antagonist to interleukin-5 for preventing or reducing eosinophilia |
05/09/1990 | EP0367590A2 Augmenting fetal hemoglobin by treatment with activin and/or inhibin |
05/09/1990 | EP0367575A1 Human lymphotoxin |
05/09/1990 | EP0367566A1 Interleukin-4 receptors |
05/09/1990 | EP0367554A2 Insulin binders and inhibitors of insulin binding |
05/09/1990 | EP0367514A2 Human leukocyte elastase inhibitors and methods for producing and using same |
05/09/1990 | EP0367489A2 Thromboresistant materials and methods for making same |
05/09/1990 | EP0367475A2 Process for producing haemoglobin concentrate |
05/09/1990 | EP0367463A1 Calcitonin gene related peptide analogues |
05/09/1990 | EP0367447A1 Human epithelial transforming growth factor |
05/09/1990 | EP0367393A2 New heterocyclic compounds, production and use thereof |
05/09/1990 | EP0367220A2 Albumin preparation and process for preparing the same |
05/09/1990 | EP0367166A1 Modified interleukin-2 and production thereof |
05/09/1990 | EP0367063A1 Isolation and cloning of complementary DNA for gene coding of bovine trophoblast protein-1 |
05/09/1990 | EP0366816A1 Recombinant platelet-derived growth factor A-chain derived from endothelial cells |
05/09/1990 | EP0366777A1 Stimulation of chemotaxis by chemotactic peptides. |
05/09/1990 | EP0366728A1 Polypeptides with fibronectin activity. |
05/09/1990 | EP0366707A1 Monoclonal antibodies to renal cell carcinoma |
05/09/1990 | EP0366669A1 Malic acid derivative containing renin inhibiting peptides |
05/09/1990 | EP0366661A1 HUMAN t-PA(u-PA) SUBSTITUTION-MUTANT PROTEINS, RECOMBINANT DNA CODING THEREFOR, TRANSFECTED HOST CELLS, PREPARATION OF THE MUTANT PROTEINS, AND PHARMACEUTICAL COMPOSITIONS |
05/09/1990 | CN1041951A Novel peptidase inhibitors |
05/09/1990 | CN1041950A Peptidase inhibitors |
05/09/1990 | CN1041878A Product for restoring, as well as stimulating and increasing hair growth |
05/09/1990 | CA2002413A1 Treatment of myelosuppression associated with acquired immune deficiency |
05/08/1990 | US4923964 Immunomodulators, thymus and spleen disorders, lymphocytes |
05/08/1990 | US4923963 Bradykinin antagonist peptides |
05/08/1990 | US4923890 Difluoro keto compounds and their use as HLE inhibitors |
05/08/1990 | US4923854 Solubilization of hydrophobic materials using lysophospholipid |
05/08/1990 | US4923851 Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
05/08/1990 | US4923815 Process for heat treating thrombin |
05/08/1990 | US4923807 Arg-Serpin human plasminogen activator inhibitor designated PAI-2 |
05/08/1990 | US4923805 Culturing cells capable of glycosylating proteins; gene expression dimerization |
05/08/1990 | US4923696 Method to prepare a neurotrophic composition |
05/08/1990 | CA1268900A1 Immunomodulators obtained by hemisynthesis of a bacterial polysaccharide isolated from a mutant strain of klebsiella pneumoniae |
05/08/1990 | CA1268899A1 Cyclic hexapeptide somatostatin analogs |